Metronomics Global Health Initiative

The Metronomics Global Health Initiative

On the Web

Latest articles

A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3
12 August
Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
28 July
metronomic maintenance for locoregionally advanced nasopharyngeal carcinoma
8 June
De-escalating cancer treatments during COVID 19 pandemic: Is metronomic chemotherapy a reasonable option?
8 December 2020
Metronomic Maintenance With Weekly Vinblastine After Induction With Bevacizumab-Irinotecan in Children With Low-grade Glioma Prevents Early Relapse
1 December 2020

Latest news

  • program of the 6th metronomic available

    the program of the next metronomic meeting in Grand Rapids is available on the dedicated post on the website

  • Maintenance chemotherapy in children with ALL is indeed metronomic chemotherapy

    A manuscript by members of MGHI has just been accepted for publication in Oncotarget. This works shows that maintenance chemotherapy in children with acute lymphoblastic leukemia exerts metronomic-like anti-endothelial effect associated with an increase in Thrombospondine-1. Read more soon in our "publication" section.

  • new ambassador from Nepal

    We are very honnored to welcome Pr. Bishnu D. Paudel from the National Academy of Medical Sciences in Kathmandu, Nepal. Pr Paudel is a pionner in palliative care in Nepal. Read more about him in the People section.

  • First Ambassador from Greece

    We are delighted to welcome Pr Briasoulis from the University of Ioannina as our first ambassador from Greece. Read more about him the "people section"